IRCT20200217046522N1
Recruiting
Phase 3
Evaluation of safety and efficacy of intavitreal injection of recombinant Tissue Plasminogen Activator before vitrectomy for diabetic Tractional Retinal Detachment on facility and outcome of surgery
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Iran University of Medical Sciences
- Enrollment
- 38
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diabetic Tractional Retinal Detachment
- •Candidated for vitrectomy
Exclusion Criteria
- •combined tractional\-rhegmatogenous retinal detachment
- •significant media opacity
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Evaluation of the efficacy and safety of intravitreal injection of ranibizumab every other month for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000005691Department of Ophthalmology, Shiga University of Medical Science40
Completed
N/A
Evaluation of the efficacy and safety of intravitreal bimonthly injection of aflibercept for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000010312Department of Ophthalmology, Shiga University of Medical Science40
Recruiting
Phase 1
Placenta-derived mesenchymal stem cells and placenta-derived mesenchymal stem cells exosomes in the treatment of acute GvHDAcute GvHD.Graft-versus-host diseaseD89.81IRCT20140818018842N40Tehran University of Medical Sciences60
Not Yet Recruiting
Phase 2
Effect of Tab HF-PRT01 in PilesCTRI/2019/04/018662SIDDHAYU AYURVEDIC RESEARCH FOUNDATIO
Recruiting
Phase 1
Safety and efficacy evaluation of using natural killer cells to treat patients with recurrent and refractory high-risk neuroblastomaIRCT20170122032121N8Kian immune cell company10